Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00108004

Public ClinicalTrials.gov record NCT00108004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 7:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Insulin Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing to achieve the desired level of glycemic control using insulin therapy.

Study identification

NCT ID
NCT00108004
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2003 (Type not available)
Primary completion
Jun 2005 (Actual)
Completion
Jun 2005 (Actual)
Last update posted
May 21, 2015

2003 – 2005

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
48
Facility City State ZIP Site status
Research Site Anaheim California — —
Research Site Escondido California — —
Research Site La Jolla California — —
Research Site Los Gatos California — —
Research Site San Francisco California — —
Research Site Torrance California — —
Research Site New Britain Connecticut — —
Research Site Norwalk Connecticut — —
Research Site Norwich Connecticut — —
Research Site Washington D.C. District of Columbia — —
Research Site Clearwater Florida — —
Research Site Orlando Florida — —
Research Site Columbus Georgia — —
Research Site Honolulu Hawaii — —
Research Site Idaho Falls Idaho — —
Research Site Indianapolis Indiana — —
Research Site Vincennes Indiana — —
Research Site Topeka Kansas — —
Research Site Wichita Kansas — —
Research Site Lexington Kentucky — —
Research Site Baltimore Maryland — —
Research Site Bloomfield Hills Michigan — —
Research Site Tupelo Mississippi — —
Research Site Las Vegas Nevada — —
Research Site Reno Nevada — —
Research Site Moorestown New Jersey — —
Research Site Neptune City New Jersey — —
Research Site Roseland New Jersey — —
Research Site New York New York — —
Research Site Williston Park New York — —
Research Site Yonkers New York — —
Research Site Greenville North Carolina — —
Research Site Lakewood Ohio — —
Research Site Westlake Ohio — —
Research Site Portland Oregon — —
Research Site Philadelphia Pennsylvania — —
Research Site Wilkes-Barre Pennsylvania — —
Research Site Charleston South Carolina — —
Research Site Sumter South Carolina — —
Research Site Chattanooga Tennessee — —
Research Site Knoxville Tennessee — —
Research Site Memphis Tennessee — —
Research Site Nashville Tennessee — —
Research Site Arlington Texas — —
Research Site Dallas Texas — —
Research Site Olympia Washington — —
Research Site Madison Wisconsin — —
Research Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00108004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 21, 2015 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00108004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →